Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C19H20N2O3 |
| Molecular Weight | 324.3737 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OCCN(CCO)C1=NC(=C(O1)C2=CC=CC=C2)C3=CC=CC=C3
InChI
InChIKey=UUCMDZWCRNZCOY-UHFFFAOYSA-N
InChI=1S/C19H20N2O3/c22-13-11-21(12-14-23)19-20-17(15-7-3-1-4-8-15)18(24-19)16-9-5-2-6-10-16/h1-10,22-23H,11-14H2
| Molecular Formula | C19H20N2O3 |
| Molecular Weight | 324.3737 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Ditazole, a non-steroidal anti-inflammatory drug with anti-aggregation activity, is marketed under the brand name Ageroplas in Spain and Portugal. Ageroplas is indicated for the prophylaxis and treatment of thrombotic vasculopathy or thromboembolic arteriosclerosis, hypertension, diabetes mellitus, vascular nephropathy, and glomerular, cardiac and vascular prostheses, phlebitis and thrombophlebitis. Ditazole also possesses analgesic and antipyretic activity.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [Ditazol in the therapy of ischemic cerebrovascular diseases. Clinical results and laboratory experiments (22-to-34-month clinical follow-up)]. | 1985-10-20 |
|
| Effect of a single Ditazole dose on platelet aggregation and prostaglandin formation. | 1984 |
|
| In vitro investigation on the antiaggregating activity of ditazole. | 1984 |
|
| [Treatment with sulfinpyrazone in comparison with ditazol. Use of dynamic ECG for the study of the cardiac rhythm in patients with recent acute myocardial infarction]. | 1983-02-28 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:25:54 GMT 2025
by
admin
on
Mon Mar 31 18:25:54 GMT 2025
|
| Record UNII |
H2BQI5Z8FT
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
B01AC01
Created by
admin on Mon Mar 31 18:25:54 GMT 2025 , Edited by admin on Mon Mar 31 18:25:54 GMT 2025
|
||
|
WHO-VATC |
QB01AC01
Created by
admin on Mon Mar 31 18:25:54 GMT 2025 , Edited by admin on Mon Mar 31 18:25:54 GMT 2025
|
||
|
NCI_THESAURUS |
C1327
Created by
admin on Mon Mar 31 18:25:54 GMT 2025 , Edited by admin on Mon Mar 31 18:25:54 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000081856
Created by
admin on Mon Mar 31 18:25:54 GMT 2025 , Edited by admin on Mon Mar 31 18:25:54 GMT 2025
|
PRIMARY | |||
|
DITAZOLE
Created by
admin on Mon Mar 31 18:25:54 GMT 2025 , Edited by admin on Mon Mar 31 18:25:54 GMT 2025
|
PRIMARY | |||
|
C65442
Created by
admin on Mon Mar 31 18:25:54 GMT 2025 , Edited by admin on Mon Mar 31 18:25:54 GMT 2025
|
PRIMARY | |||
|
DB08994
Created by
admin on Mon Mar 31 18:25:54 GMT 2025 , Edited by admin on Mon Mar 31 18:25:54 GMT 2025
|
PRIMARY | |||
|
H2BQI5Z8FT
Created by
admin on Mon Mar 31 18:25:54 GMT 2025 , Edited by admin on Mon Mar 31 18:25:54 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104306
Created by
admin on Mon Mar 31 18:25:54 GMT 2025 , Edited by admin on Mon Mar 31 18:25:54 GMT 2025
|
PRIMARY | |||
|
242-353-5
Created by
admin on Mon Mar 31 18:25:54 GMT 2025 , Edited by admin on Mon Mar 31 18:25:54 GMT 2025
|
PRIMARY | |||
|
SUB06328MIG
Created by
admin on Mon Mar 31 18:25:54 GMT 2025 , Edited by admin on Mon Mar 31 18:25:54 GMT 2025
|
PRIMARY | |||
|
DTXSID3022954
Created by
admin on Mon Mar 31 18:25:54 GMT 2025 , Edited by admin on Mon Mar 31 18:25:54 GMT 2025
|
PRIMARY | |||
|
29088
Created by
admin on Mon Mar 31 18:25:54 GMT 2025 , Edited by admin on Mon Mar 31 18:25:54 GMT 2025
|
PRIMARY | |||
|
18471-20-0
Created by
admin on Mon Mar 31 18:25:54 GMT 2025 , Edited by admin on Mon Mar 31 18:25:54 GMT 2025
|
PRIMARY | |||
|
929
Created by
admin on Mon Mar 31 18:25:54 GMT 2025 , Edited by admin on Mon Mar 31 18:25:54 GMT 2025
|
PRIMARY | |||
|
m4680
Created by
admin on Mon Mar 31 18:25:54 GMT 2025 , Edited by admin on Mon Mar 31 18:25:54 GMT 2025
|
PRIMARY | Merck Index | ||
|
2603
Created by
admin on Mon Mar 31 18:25:54 GMT 2025 , Edited by admin on Mon Mar 31 18:25:54 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |